Bank Julius Baer & Co. Ltd, Zurich Dr Reddys Laboratories LTD Transaction History
Bank Julius Baer & Co. Ltd, Zurich
- $29.1 Billion
- Q4 2024
A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 4,531 shares of RDY stock, worth $62,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,531Holding current value
$62,935% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RDY
# of Institutions
258Shares Held
38.2MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$159 Million0.35% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa2.47MShares$34.3 Million0.02% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31.1 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$27.7 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27.1 Million0.25% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...